Simplex Trading’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNY
TI
OMC
MCA
FFA
SIS
GSEP
Simplex Trading's MRNY Position: Q1 2026 in Review
Simplex Trading sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026, closing a stake of 491 shares — an estimated $7.22K sold.
Simplex Trading first reported a position in MRNY in Q3 2025 and held it in 2 quarters. The position peaked at $7.22K in Q4 2025. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.
- Simplex Trading reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 491 YieldMax MRNA Option Income Strategy ETF shares in Q1 2026, an estimated $7.22K.
- Simplex Trading first reported a position in YieldMax MRNA Option Income Strategy ETF in Q3 2025 and held it in 2 quarters.
- Simplex Trading's YieldMax MRNA Option Income Strategy ETF position peaked at $7.22K in Q4 2025.
- 11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.